Ochre - A National Cancer Charity - Company Profile

POWER SEARCH PRICING

SOLUTIONS

ochre - a national cancer charity Company Information

Company Number

SC224419

Next Accounts

Dec 2025

Directors

Hosney Yosef

Susan Kee

View All

Shareholders

Group Structure

View All

Industry

Other personal service activities n.e.c.

Registered Address

office 8,, caledonia business centre, glasgow, G46 8JT

Website

http://ochrecharity.org.uk

ochre - a national cancer charity Estimated Valuation

£1.5m

Pomanda estimates the enterprise value of OCHRE - A NATIONAL CANCER CHARITY at £1.5m based on a Turnover of £2.8m and 0.52x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Ochre - A National Cancer Charity is a live company located in glasgow, G46 8JT with a Companies House number of SC224419. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in October 2001, it's largest shareholder is unknown. Ochre - A National Cancer Charity is a mature, small sized company, Pomanda has estimated its turnover at £2.8m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ochre - A National Cancer Charity a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

2 Strong

2 Regular

4 Weak

Size

annual sales of £2.8m, make it larger than the average company (£848.9k)

Growth

3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (8.2%)

EXPORT

Ochre - A National Cancer Charity's latest turnover from March 2024 is estimated at £2.8 million and the company has net assets of £482 thousand. According to their latest financial statements, we estimate that Ochre - A National Cancer Charity has 16 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013	Oct 2012	Oct 2011	Oct 2010	Oct 2009
Turnover	2,805,046	2,682,391	2,319,236	2,376,659	2,390,684	2,266,995	1,231,829	1,239,571	990,694	126	1,404	37	38	10,315
Other Income Or Grants
Cost Of Sales	2,268,545	2,163,855	1,890,852	1,962,995	1,928,157	1,823,221	980,048	975,960	779,691	100	1,095	29	29	7,867
Gross Profit	536,501	518,535	428,384	413,664	462,527	443,774	251,781	263,611	211,003	26	309	8	8	2,448
Admin Expenses	538,884	464,439	423,885	-125,759	432,711	387,816	227,440	162,911	163,366	-17,946	-43,009	-12,777	-15,292	6,393	-222,029
Operating Profit	-2,383	54,096	4,499	539,423	29,816	55,958	24,341	100,700	47,637	17,972	43,318	12,785	15,300	-3,945	222,029
Interest Payable
Interest Receivable									571	1,106	983	871	824	802	400
Pre-Tax Profit	-2,383	54,096	4,499	539,423	29,816	55,958	24,341	100,700	48,209	19,078	44,301	13,655	16,124	-3,143	222,429
Tax		-10,278	-855	-102,490	-5,665	-10,632	-4,625	-20,140	-9,642	-4,006	-10,189	-3,277	-4,192		-62,280
Profit After Tax	-2,383	43,818	3,644	436,933	24,151	45,326	19,716	80,560	38,567	15,072	34,112	10,378	11,932	-3,143	160,149
Dividends Paid
Retained Profit	-2,383	43,818	3,644	436,933	24,151	45,326	19,716	80,560	38,567	15,072	34,112	10,378	11,932	-3,143	160,149
Employee Costs	464,025	452,197	407,038	406,982	377,484	362,340	197,585	212,462	158,822	26,130	25,877	25,826	25,489	24,623
Number Of Employees	16	16	15	16	14	14	8	8	6	1	1	1	1	1
EBITDA*	-2,383	54,096	4,499	539,423	29,816	55,958	24,341	100,700	47,637	17,972	43,318	12,785	15,300	-3,945	222,029

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013	Oct 2012	Oct 2011	Oct 2010	Oct 2009
Tangible Assets	6,600
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	6,600
Stock & work in progress
Trade Debtors	475,411	484,395	440,577	436,933	436,820	412,669	367,409	347,693	267,107					1,555
Group Debtors
Misc Debtors
Cash										228,540	213,875	179,330	168,953	160,625	160,149
misc current assets	1
total current assets	475,412	484,395	440,577	436,933	436,820	412,669	367,409	347,693	267,107	228,540	213,875	179,330	168,953	162,180	160,149
total assets	482,012	484,395	440,577	436,933	436,820	412,669	367,409	347,693	267,107	228,540	213,875	179,330	168,953	162,180	160,149
Bank overdraft
Bank loan
Trade Creditors							66	66	40	40	447	14	15	5,174
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities							66	66	40	40	447	14	15	5,174
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities							66	66	40	40	447	14	15	5,174
net assets	482,012	484,395	440,577	436,933	436,820	412,669	367,343	347,627	267,067	228,500	213,428	179,316	168,938	157,006	160,149
total shareholders funds	482,012	484,395	440,577	436,933	436,820	412,669	367,343	347,627	267,067	228,500	213,428	179,316	168,938	157,006	160,149

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013	Oct 2012	Oct 2011	Oct 2010	Oct 2009
Operating Activities
Operating Profit	-2,383	54,096	4,499	539,423	29,816	55,958	24,341	100,700	47,637	17,972	43,318	12,785	15,300	-3,945	222,029
Depreciation
Amortisation
Tax		-10,278	-855	-102,490	-5,665	-10,632	-4,625	-20,140	-9,642	-4,006	-10,189	-3,277	-4,192		-62,280
Stock
Debtors	-8,984	43,818	3,644	436,933	24,151	45,260	19,716	80,586	267,107				-1,555	1,555
Creditors						-66		26		-407	433	-1	-5,159	5,174
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations	6,601								-229,112	13,559	33,562	9,507	7,504	-326	159,749
Investing Activities
capital expenditure	-6,600
Change in Investments
cash flow from investments	-6,600
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest									571	1,106	983	871	824	802	400
cash flow from financing									571	1,106	983	871	824	802	400
cash and cash equivalents
cash									-228,540	14,665	34,545	10,377	8,328	476	160,149
overdraft
change in cash									-228,540	14,665	34,545	10,377	8,328	476	160,149

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ochre - a national cancer charity. Get real-time insights into ochre - a national cancer charity's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ochre - a national cancer charity by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other small companies, companies in G46 area or any other competitors across 12 key performance metrics.

OCHRE - A NATIONAL CANCER CHARITY group structure

Ochre - A National Cancer Charity has no subsidiary companies.

Ultimate parent company

OCHRE - A NATIONAL CANCER CHARITY

SC224419

OCHRE - A NATIONAL CANCER CHARITY Shareholders

Ochre - A National Cancer Charity currently has 8 directors. The longest serving directors include Dr Hosney Yosef (Oct 2001) and Ms Susan Kee (Jul 2004).

officer	country	age	start	end	role
Dr Hosney Yosef		82 years	Oct 2001	-	Director
Ms Susan Kee		48 years	Jul 2004	-	Director
Mr John Graham		80 years	Jul 2004	-	Director
Mr Allan Lapsley		70 years	Oct 2007	-	Director
Dr David McIntosh	Scotland	46 years	Dec 2013	-	Director
Professor Russell Petty	Scotland	53 years	Nov 2023	-	Director
Mr Donald McArthur	Scotland	48 years	Nov 2023	-	Director
Mr Darren McAllister	United Kingdom	43 years	Nov 2023	-	Director

P&L

March 2024

turnover

2.8m

+5%

operating profit

-2.4k

gross margin

19.2%

-1.06%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

482k

total assets

482k

cash

net assets

Total assets minus all liabilities

Similar Companies

scotech welding supplies limited

damada (asbestos removals) limited

3.5

lift maintenance limited

tankwash scotland limited

3.5

nmc drainage ltd.

company number

SC224419

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

96090 - Other personal service activities n.e.c.

incorporation date

October 2001

ultimate parent company

None

previous names

N/A

address

office 8,, caledonia business centre, glasgow, G46 8JT

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ochre - a national cancer charity.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for OCHRE - A NATIONAL CANCER CHARITY. This can take several minutes, an email will notify you when this has completed.

ochre - a national cancer charity

ochre - a national cancer charity Company Information

ochre - a national cancer charity Estimated Valuation

ochre - a national cancer charity Estimated Valuation

ochre - a national cancer charity Estimated Valuation

Ochre - A National Cancer Charity Overview

Ochre - A National Cancer Charity Health Check

OCHRE - A NATIONAL CANCER CHARITY financials

ochre - a national cancer charity Credit Report and Business Information

Ochre - A National Cancer Charity Competitor Analysis

ochre - a national cancer charity Ownership

ochre - a national cancer charity directors

ochre - a national cancer charity company details

ochre - a national cancer charity Charges & Mortgages

ochre - a national cancer charity Capital Raised & Share Issues BETA

ochre - a national cancer charity Companies House Filings - See Documents